Health Cor Management, L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Health Cor Management, L.P.

$106 Million
Q4 2022

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $5.25 Million - $7.07 Million	-9,570 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $11.2 Million - $13.1 Million	-18,750 Reduced 66.21%	9,570 $6.68 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $15.4 Million - $19 Million	28,320 New	28,320 $17.9 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $109 Million - $130 Million	-190,380 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $90 Million - $106 Million	190,380 New	190,380 $106 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $91 Million - $116 Million	-190,310 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $72.9 Million - $88 Million	133,760 Added 236.53%	190,310 $107 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $27.9 Million - $36.4 Million	56,550 New	56,550 $35.3 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $125 Million - $184 Million	-372,770 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $102 Million - $140 Million	372,770 New	372,770 $140 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $164 Million - $194 Million	-440,968 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $61.8 Million - $74.2 Million	-184,032 Reduced 29.45%	440,968 $165 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $75.6 Million - $90.7 Million	225,000 Added 56.25%	625,000 $216 Million
Q3 2018 Nov 15, 2018	SELL	$351.14 - $408.51 $79 Million - $91.9 Million	-225,000 Reduced 36.0%	400,000 $162 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $94.7 Million - $118 Million	300,000 Added 92.31%	625,000 $215 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $117 Million - $153 Million	325,000	325,000 $122 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.

Account